Advertisement
Canada markets close in 4 hours 43 minutes
  • S&P/TSX

    21,750.18
    -123.54 (-0.56%)
     
  • S&P 500

    5,003.39
    -68.24 (-1.35%)
     
  • DOW

    37,812.88
    -648.04 (-1.68%)
     
  • CAD/USD

    0.7296
    -0.0002 (-0.02%)
     
  • CRUDE OIL

    82.35
    -0.46 (-0.56%)
     
  • Bitcoin CAD

    87,022.28
    -2,067.02 (-2.32%)
     
  • CMC Crypto 200

    1,371.23
    -11.34 (-0.82%)
     
  • GOLD FUTURES

    2,346.80
    +8.40 (+0.36%)
     
  • RUSSELL 2000

    1,966.63
    -28.80 (-1.44%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ

    15,438.56
    -274.18 (-1.74%)
     
  • VOLATILITY

    17.05
    +1.08 (+6.77%)
     
  • FTSE

    8,068.11
    +27.73 (+0.34%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6808
    -0.0011 (-0.16%)
     

Mylan Stock Falls on Analyst Downgrade, Trades at 52-Week Low

Mylan Stock Falls on Analyst Downgrade, Trades at 52-Week Low

Today, Morgan Stanley downgraded Mylan (MYL) from “overweight” to “equal weight.” The firm also cut its target price for MYL stock from $46 to $36. Also, Mylan has seen lower-than-expected sales from its biosimilar and complex products portfolio, which it’s increasingly focusing on in the wake of increasing generics competition and pricing pressures. Today, MYL stock fell ~2.7% during premarket trading.